Annual Total Expenses
$4.44 M
-$3.14 M-41.37%
31 March 2024
Summary:
China SXT Pharmaceuticals annual total expenses is currently $4.44 million, with the most recent change of -$3.14 million (-41.37%) on 31 March 2024. During the last 3 years, it has fallen by -$2.53 million (-36.29%). SXTC annual total expenses is now -42.97% below its all-time high of $7.79 million, reached on 31 March 2022.SXTC Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SXTC Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.4% | - |
| 3 y3 years | -36.3% | - |
| 5 y5 years | -15.2% | - |
SXTC Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.0% | at low | ||
| 5 y | 5 years | -43.0% | at low | ||
| alltime | all time | -43.0% | +35.5% |
China SXT Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $4.44 M(-41.4%) | - |
| Mar 2023 | $7.58 M(-2.7%) | - |
| Mar 2022 | $7.79 M(+11.7%) | - |
| Mar 2021 | $6.97 M(+7.2%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | $6.50 M(+24.1%) | - |
| Mar 2019 | $5.24 M(-2.7%) | - |
| Mar 2018 | $5.39 M(+64.3%) | - |
| Mar 2017 | $3.28 M | - |
FAQ
- What is China SXT Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for China SXT Pharmaceuticals?
- What is China SXT Pharmaceuticals annual total expenses year-on-year change?
What is China SXT Pharmaceuticals annual total expenses?
The current annual total expenses of SXTC is $4.44 M
What is the all time high annual total expenses for China SXT Pharmaceuticals?
China SXT Pharmaceuticals all-time high annual total expenses is $7.79 M
What is China SXT Pharmaceuticals annual total expenses year-on-year change?
Over the past year, SXTC annual total expenses has changed by -$3.14 M (-41.37%)